Recent Company News

• 01:02 AM ET Sep 16, 2026
  

  bioMerieux receives IVDR Class D CE Marking for BIOFIRE Respiratory 2.1 plus Panel and BIOFIRE FILMARRAY Pneumonia plus Panel (€72.80, 0.00)

• 09:00 AM ET Jul 28, 2026
  

  Transcript Intelligence: bioMerieux Q2 Earnings Themes

• 09:00 AM ET Jul 28, 2026
  

  Transcript Intelligence: bioMerieux Q2 Earnings Guidance

• 09:00 AM ET Jul 28, 2026
  

  Transcript Intelligence: bioMerieux Q2 Earnings Q&A

• 01:11 AM ET Jul 28, 2026
  

  bioMerieux reports H1 EPS €1.99 vs FactSet €2.03 [1 est] (€70.70, 0.00)

• 01:01 AM ET Jun 30, 2026
  

  bioMerieux submits 510(k) to FDA for the latest versions of the BIOFIRE FILMARRAY gastrointestinal panels (€69.85, 0.00)

• 02:55 AM ET Jun 26, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:06 AM ET Jun 26, 2026
  

  bioMerieux has submitted a Dual 510(k)/CLIA Waiver application to the FDA for the BIOFIRE SPOTFIRE Vaginitis (VG) Panel (€70.10, 0.00)

• 01:50 AM ET Jun 25, 2026
  

  Kepler Cheuvreux initiates BIM.FP, DIA.IM, QIA.GR

• 04:42 AM ET Jun 23, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (82 total)